Aktien aus dem Gesundheitswesen
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 1172 |  STVN Stevanato Group S.p.A. Ordinary Shares | 18.72 USD | +0.70% | +2.24% | +7.09% | -16.09% | 5.67 B USD | ||
| 1180 |  CHE Chemed Corp | 422.80 USD | -0.80% | -1.75% | +0.54% | -25.69% | 5.61 B USD | ||
| 1183 |  TFX Teleflex Incorporated Common Stock | 126.25 USD | -1.86% | -5.54% | +3.66% | +3.48% | 5.59 B USD | ||
| 1192 |  BLCO Bausch + Lomb Corporation Common Shares | 15.41 USD | -1.60% | -3.26% | -4.88% | -0.06% | 5.49 B USD | ||
| 1212 |  LQDA Liquidia Corporation - Common Stock | 58.75 USD | +9397.25% | -4.05% | +52.76% | +159.96% | 5.22 B USD | ||
| 1217 |  APLS Apellis Pharmaceuticals, Inc. - Common Stock | 41.03 USD | -0.07% | -0.02% | +0.37% | +131.94% | 5.25 B USD | ||
| 1221 |  CRSP CRISPR Therapeutics AG - Common Shares | 54.18 USD | -3.56% | +6.91% | +4.66% | +47.47% | 5.23 B USD | ||
| 1223 |  CGON CG Oncology, Inc. - Common stock | 59.23 USD | +9408.75% | -7.45% | -11.21% | +35.97% | 5.22 B USD | ||
| 1230 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 53.41 USD | -2.41% | -1.48% | -4.39% | +30.94% | 5.16 B USD | ||
| 1245 |  APGE Apogee Therapeutics, Inc. - Common Stock | 79.30 USD | -3.46% | -3.57% | -1.65% | +47.98% | 4.91 B USD | ||
| 1264 |  DNTH Dianthus Therapeutics, Inc. - Common Stock | 89.45 USD | -3.83% | +2.18% | +2.84% | +409.98% | 4.89 B USD | ||
| 1286 |  CAI Caris Life Sciences, Inc. - Common Stock | 16.45 USD | +9738.52% | +4.71% | -10.31% | -39.07% | 4.65 B USD | ||
| 1297 |  LEGN Legend Biotech Corporation - American Depositary Shares | 25.51 USD | +9292.49% | -13.23% | +8.14% | -20.23% | 4.72 B USD | ||
| 1319 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 2.30 USD | -0.94% | -99.00% | -98.98% | -98.77% | 46.05 M USD | ||
| 1327 |  NNNN Anbio Biotechnology - Class A Ordinary Shares | 31.00 USD | -12.23% | -2.55% | +6.53% | +17.25% | 4.46 B USD | ||
| 1331 |  BLLN BillionToOne, Inc. - Class A common stock | 91.12 USD | -7.95% | +5.57% | +17.59% | -8.88% | 4.19 B USD | ||
| 1342 |  MANE Veradermics, Incorporated Common Stock | 104.33 USD | +3.25% | +3.30% | +3.89% | +216.15% | 4.36 B USD | ||
| 1351 |  TVTX Travere Therapeutics, Inc. - Common Stock | 0.45 USD | -99.05% | -98.99% | -98.98% | -98.44% | 41.88 M USD | ||
| 1353 |  ERAS Erasca, Inc. - Common Stock | 13.82 USD | +7.63% | +21.65% | +38.20% | +873.24% | 4.30 B USD | ||
| 1357 |  INDV Indivior Pharmaceuticals, Inc. - Common Stock | 34.88 USD | -3.16% | -7.85% | -10.22% | +3.81% | 4.25 B USD |
Nachrichten Aktien aus dem Gesundheitswesen
Star Equity Holdings: CEO Jeffrey Eberwein kauft Aktien im Wert von 195.611 $
Alpha Teknova: Aufsichtsratsmitglied scheidet aus, Aktionäre bestätigen Direktoren und Wirtschaftsprüfer
Teleflex platziert Vorrangige Anleihe über 500 Mio. US-Dollar mit 5,875 % Kupon
Korro Bio: Direktor veräußert Aktien im Wert von knapp 40.000 US-Dollar
Fulcrum Therapeutics: Aktie stürzt nach Entwicklungsstopp für Sichelzell-Medikament ab
Abivax: Aktie bricht trotz positiver Studiendaten um 40 % ein
Wolfe Research startet Coverage für Repligen-Aktie mit "Outperform"
Gainers Aktien aus dem Gesundheitswesen
 EWTX Edgewise Therapeutics, Inc. - Common Stock | 40.26 | +11685.71% |
 MBIO Mustang Bio, Inc. - Common Stock | 0.77 | +11392.54% |
 PMI Picard Medical, Inc. Common Stock | 0.17 | +11233.33% |
 HYPD Hyperion DeFi, Inc. - Common Stock | 3.86 | +10928.57% |
 CLYM Climb Bio, Inc. - Common Stock | 11.80 | +10666.42% |
 KPRX Kiora Pharmaceuticals, Inc. - Common Stock | 2.87 | +10608.96% |
 ADGM Adagio Medical Holdings, Inc - Common Stock | 0.77 | +10594.44% |
 ORIC Oric Pharmaceuticals, Inc. - Common Stock | 8.98 | +10527.22% |
